AcelRx Pharmaceuticals Inc. (ACRX)

2.20
NASDAQ : Health Technology
Prev Close 2.25
Day Low/High 2.16 / 2.27
52 Wk Low/High 1.99 / 5.05
Avg Volume 1.22M
Exchange NASDAQ
Shares Outstanding 79.44M
Market Cap 178.73M
EPS -0.80
P/E Ratio N/A
Div & Yield N.A. (N.A)

Sailing Stormy Seas, Plus Updates on 3 Positions

Here’s when we would consider adding to Aurora Cannabis.

First Week Of June 2019 Options Trading For AcelRx Pharmaceuticals (ACRX)

First Week Of June 2019 Options Trading For AcelRx Pharmaceuticals (ACRX)

Investors in AcelRx Pharmaceuticals Inc saw new options become available this week, for the June 2019 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 239 days until expiration the newly available contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Stocks Under $10 Weekly Summary

Amid volatile market activity, we added to four positions last week.

Adding to the Portfolio’s ‘Wild Child’

We are buying more shares of AcelRx Pharmaceuticals following an FDA advisory committee’s approval of its NDA candidate.

Stocks Under $10 Weekly Summary

The majority of our positions outperformed our benchmark during a challenging week for the stock market.

Insiders Seeing Green With ACRX At New 52-Week High

Insiders Seeing Green With ACRX At New 52-Week High

In trading on Monday, shares of AcelRx Pharmaceuticals Inc touched a new 52-week high of $5.03/share. That's a 224.52% rise, or $3.48 per share from the 52-week low of $1.55 set back on 10/19/2017.

It’s a Key Day for This Specialty Pharma Position

FDA review of AcelRx Pharma's DSUVIA should produce a significant reaction in the shares.

Stocks Under $10 Weekly Summary

We added to four positions during a rough week for small-cap names.

Stocks Under $10 Weekly Summary

We initiated a new position and added to a newer name during a mixed week for the portfolio.

Analyzing a Position’s Ups and Downs

There are several reasons to believe in AcelRx Pharmaceuticals’ recent rise.

Stocks Under $10 Weekly Summary

Last week was a frenetic one for the portfolio as we scaled into one name, added another to the fold, and booked some hefty profits in a cannabis stock.

Stocks Under $10 Weekly Summary

Last week we re-initiated a position in Aurora Cannabis, exited USA Technologies and added to our holdings in Del Frisco's Restaurant Group.

Stocks Under $10 Weekly Summary

We added a starter a position in Parateum Corp. during a challenging week for the portfolio.

Stocks Under $10 Weekly Summary

We added 2 new positions last week as the portfolio finished the summer strong.

Stocks Under $10 Weekly Summary

Last week was a busy one for the portfolio as we exited 3 positions.

Stocks Under $10 Weekly Summary

There were several bright spots in the portfolio last week, including Habit Restaurants and USA Technologies.

Stocks Under $10 Weekly Summary

The portfolio had several big winners last week as shares of Habit Restaurants and Energy Recovery soared.

A Positive Reaction For These Two Companies Following Q2 Earnings

While ArcelRx Pharmaceuticals faces key milestones, I'm excited about Energy Recovery.

Stocks Under $10 Weekly Summary

We trimmed one position and added to another last week as smaller-cap stocks took a hit.

Stocks Under $10 Weekly Summary

During a week that showed little change for the major stock market indices, the portfolio had a number of outperformers.

Stocks Under $10 Weekly Summary

Similar to the Russell 2000 trading off last week so too did a number of our holdings, although there were bright spots as well.

Update and Target Change on Healthcare Holding

Winning position AcelRx recently announced a public offering.

Updates on 8 Portfolio Positions

A look at several of our positions over the past week.

Stocks Under $10 Weekly Summary

It was a challenging week for the portfolio amid continued trade and tariff concerns.

Stocks Under $10 Weekly Summary

It was a good week for the portfolio, as a large majority of positions outperformed the market.

Stocks Under $10 Weekly Summary

Last week, we initiated a position in Farmland Partners and trimmed our holdings in AcelRx Pharmaceuticals.

Trimming a Position on Strength

We will sell some of our AcelRx holdings as the stock moves through out current price target.

Read All About It! Positive News on Four Positions

We still like all of these names after developments this week.

Stocks Under $10 Weekly Summary

During the week we scaled into two existing positions and added back shares of a former holding.

Stocks Under $10 Weekly Summary

During the week we added to our cannabis play Kush Bottles and took a nice win on J.Jill.

TheStreet Quant Rating: D- (Sell)